Many Trial Reports on FDA-Approved Drugs Go Unpublished
Selective reporting may color record of comparisons to other meds, study says
Group Works to Streamline Cancer Therapy Approvals
6-point flow chart seeks to clarify most productive research lines for FDA consideration
Anti-Nausea Patch Approved for Chemo Patients
Protects for up to 5 days
Gardasil Approved for Additional Uses
To help protect women against two more cancers
Keppra XR Approved for Partial-Onset Seizures
For people 16 and older
New Test Identifies Heart Transplant Rejection
Monitors gene activity in white blood cells
Bone Marrow Treatment Approved for Rare Bleeding Disorder
Stimulates marrow to compensate for low platelet count
First Treatment Sanctioned for Chorea in Huntingtons Patients
The involuntary jerky movements that accompany the disease
New Lymphoma Drug Shows Promise
Eleven of 38 non-Hodgkin patients respond to blinatumomab, study finds
Viread Approved for Hepatitis B
Already sanctioned to treat HIV
| Next > |